Improving health and outcomes of patients suffering various types of diseases or illnesses is one of the toughest challenges faced by the medical community today. Medical Nutrition is increasingly recognised as a key to effective disease management and improving clinical outcomes.

As a leading global Neutraceutical company, British Biologicals is engaged in the discovery, development, manufacturing and commercialisation of innovative Medical nutrition products for disease specific conditions. Criticare - a new division of British Biologicals was started in 2009 with the sole objective of providing nutritional products to patients admitted to hospitals for various illnesses to improve clinical outcomes.

Our products range includes Renopro and Renopro High protein for Chronic kidney disease, Cardiopro for heart diseases, thrombolysis, angioplasty and CABG, Supplement – D for diabetes, Nutrizen for wound healing following surgery, trauma and minor accidents and Promaxe for Hyper metablic state including Cancer, burns and infectious diseases and others.

Research to develop new products is one of our top priorities. Our long-term strategy is to develop products that can be used in a Critical care setting.